Role of paroxetine in the management of hot flashes in gyn cancer survivors (randomized single-center controlled trial) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Sunday, October 16, 2016

Role of paroxetine in the management of hot flashes in gyn cancer survivors (randomized single-center controlled trial)



 Pronunciation
Generic Name: paroxetine (pa ROX a teen)
Brand Names: Brisdelle, Paxil, Paxil CR, Pexeva
 Paroxetine, also known by the trade names Paxil and Seroxat among others
                              ~~~~~~~~~~~~~~~~~~~~~~~
abstract:
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial
  

Highlights

  • To examine the effects of paroxetine supplementation on hot flashes and sleep in gynecological cancer survivors
  • We compared 7.5 mg oral paroxetine or placebo daily for 16 weeks in gynecological cancer survivors.
  • Paroxetine 7.5 mg significantly reduces hot flashes in weekly frequency and severity in gynecological cancer survivors.

0 comments :

Post a Comment

Your comments?